RACGP - Four things about mRNA vaccines researchers still want to find out
mRNA structure regulates protein expression through changes in functional half-life | PNAS
Moderna designed its coronavirus vaccine in 2 days — here's how - National | Globalnews.ca
This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines | Science | AAAS
Moderna (MRNA), Pfizer (PFE) Covid-19 Vaccines Look Strong. How They Compare - Bloomberg
Frontiers | SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Moderna mRNA-1273, COVID-19 vaccine
Read Public Citizen's Letter on the Moderna Vaccine Patent Dispute - The New York Times
Short identical gene sequence in SARS-CoV-2 and a gene sequence patented by Moderna can be found in other organisms; not evidence that virus was engineered - Health Feedback
The tangled history of mRNA vaccines
Moderna, Inc. - Dr. Jacqueline Miller, Moderna's SVP, Infectious Diseases Development, is now presenting on the clinical development update of our COVID-19 vaccine candidate, mRNA-1273. https://buff.ly/2RBY69W | Facebook
Frontiers | MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site
How Moderna made its mRNA Covid vaccine so quickly: Noubar Afeyan
A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice | Cell Research
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society
NIAID and Moderna scientists describe SARS-CoV-2 vaccine development
Moderna on Twitter: "Accelerated research and development timelines are a potential advantage of #mRNA vaccines https://t.co/s51Ex9k6dJ" / Twitter
Moderna Designed Its Coronavirus Vaccine in Just 2 Days
mRNA vaccines for infectious diseases: principles, delivery and clinical translation | Nature Reviews Drug Discovery
Vaccines | Free Full-Text | Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science
The promise of mRNA vaccines: a biotech and industrial perspective | npj Vaccines
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability - ScienceDirect
RNA Vaccines (mRNA Vaccine) - Basis of Pfizer and Moderna COVID-19 vaccines, Animation - YouTube
